These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15637895)

  • 21. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management strategies for poor peripheral blood stem cell mobilization.
    Moog R
    Transfus Apher Sci; 2008 Jun; 38(3):229-36. PubMed ID: 18485822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-10 gene polymorphism in bone marrow transplant recipients.
    Azarpira N; Ramzi M; Aghdaie MH; Darai M; Geramizadeh B
    Exp Clin Transplant; 2008 Mar; 6(1):74-9. PubMed ID: 18405249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia].
    Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent progress in hematopoietic stem cell transplantation].
    Shinagawa K
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):727-35. PubMed ID: 16770089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern treatment of leukemia and hematopoietic stem cell transplantation].
    Pejin D; Stefanović N; Belić A; Popović S; Spasojević J; Uzurov V; Savić I; Savić A
    Med Pregl; 1997; 50(11-12):473-9. PubMed ID: 9471506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-myeloablative conditioning for hemopoietic stem cell transplantation--does it work?
    Cheong SK; Eow GI; Leong CF
    Malays J Pathol; 2002 Jun; 24(1):1-8. PubMed ID: 16329549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy progress and prospects: stem cell plasticity.
    Kashofer K; Bonnet D
    Gene Ther; 2005 Aug; 12(16):1229-34. PubMed ID: 15973440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation.
    Yamaguchi M; Maekawa M; Nakamura Y; Ueda M
    Am J Hematol; 2005 Oct; 80(2):124-7. PubMed ID: 16184583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
    Pelus LM; Fukuda S
    Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
    Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
    Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
    Iino M; Nakajima A; Shindo H
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B; Jordanova M; Michailov G; Konstantinov D; Christosova I; Bobev D
    J BUON; 2006; 11(4):433-8. PubMed ID: 17309174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.